OR.38. Pathogenic Role of IL-6 and Effective Mechanism of IL-6 Blocking Therapy for Autoimmune Disease Both at Initial Immunological Phase and Late Chronic Inflammatory Phase

Kazuyuki Yoshizaki

doi:10.1016/j.clim.2009.03.045

OR.38. Pathogenic Role of IL-6 and Effective Mechanism of IL-6 Blocking Therapy for Autoimmune Disease Both at Initial Immunological Phase and Late Chronic Inflammatory Phase

Kazuyuki Yoshizaki

https://doi.org/10.1016/j.clim.2009.03.045

Copy DOI

Export

Save

Cite

Journal: Clinical Immunology

Publication Date: Jan 1, 2009

Affiliation: Osaka University

#Initial Chronic Phase #Late Inflammatory Phase #Initial Inflammatory Phase #Late Chronic Phase #Therapy For Disease #Chronic Phase #Late Phase #Initial Phase #IL-6 Blocking Therapy #Chronic Inflammatory Phase

Abstract
Full-Text
Similar Papers

Abstract

Listen

OR.38. Pathogenic Role of IL-6 and Effective Mechanism of IL-6 Blocking Therapy for Autoimmune Disease Both at Initial Immunological Phase and Late Chronic Inflammatory Phase

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Clinical Immunology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

OR.38. Pathogenic Role of IL-6 and Effective Mechanism of IL-6 Blocking Therapy for Autoimmune Disease Both at Initial Immunological Phase and Late Chronic Inflammatory Phase